Pricing
Login
Home
Charts
Search
Watchlist
Products

Tatva Chintan Pharma Chem Ltd

TATVA
₹1,601.80-2.16%20 Nov 2026
Reports
Specialty Chemicals

Tatva Chintan Pharma Chem Ltd

TATVA
₹1,601.80
-2.16%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹3,747Cr
Close
Close Price
₹1,601.80
Industry
Industry
Specialty Chemicals
PE
Price To Earnings
59.55
PS
Price To Sales
5.77
Revenue
Revenue
₹650Cr
Rev Gr TTM
Revenue Growth TTM
49.69%
PAT Gr TTM
PAT Growth TTM
254.68%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
84981058386108117124131134167217
Growth YoY
Revenue Growth YoY%
-30.2-21.1-7.8-13.62.09.810.848.052.924.443.075.9
Expenses
ExpensesCr
738393787999100101106106135177
Operating Profit
Operating ProfitCr
111613679172225283241
OPM
OPM%
13.115.912.06.78.28.314.818.019.421.019.318.7
Other Income
Other IncomeCr
151001112012
Interest Expense
Interest ExpenseCr
000000010123
Depreciation
DepreciationCr
767777999101111
PBT
PBTCr
5147-10291418172129
Tax
TaxCr
242001242657
PAT
PATCr
3105-10171015101621
Growth YoY
PAT Growth YoY%
-70.2-43.3-45.2-108.5-96.0-89.327.61,603.010,735.7901.9140.3116.2
NPM
NPM%
4.19.84.9-0.80.20.95.78.011.67.79.69.9
EPS
EPS₹
1.54.12.2-0.30.10.42.84.26.54.46.89.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
84981058386108117124131134167217
Growth YoY
Revenue Growth YoY%
-30.2-21.1-7.8-13.62.09.810.848.052.924.443.075.9
Expenses
ExpensesCr
738393787999100101106106135177
Operating Profit
Operating ProfitCr
111613679172225283241
OPM
OPM%
13.115.912.06.78.28.314.818.019.421.019.318.7
Other Income
Other IncomeCr
151001112012
Interest Expense
Interest ExpenseCr
000000010123
Depreciation
DepreciationCr
767777999101111
PBT
PBTCr
5147-10291418172129
Tax
TaxCr
242001242657
PAT
PATCr
3105-10171015101621
Growth YoY
PAT Growth YoY%
-70.2-43.3-45.2-108.5-96.0-89.327.61,603.010,735.7901.9140.3116.2
NPM
NPM%
4.19.84.9-0.80.20.95.78.011.67.79.69.9
EPS
EPS₹
1.54.12.2-0.30.10.42.84.26.54.46.89.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
136206263300434424394383506650
Growth
Revenue Growth%
51.927.614.144.4-2.3-7.1-2.732.249.7
Expenses
ExpensesCr
113173208234325363325349413523
Operating Profit
Operating ProfitCr
2334556610861683493127
OPM
OPM%
16.916.420.922.125.014.317.38.918.419.5
Other Income
Other IncomeCr
1115928245
Interest Expense
Interest ExpenseCr
2444587137
Depreciation
DepreciationCr
345781026283740
PBT
PBTCr
19274861104454485784
Tax
TaxCr
771088-11321521
PAT
PATCr
1221385296453064263
Growth
PAT Growth%
67.284.038.383.5-52.6-33.3-81.2636.1254.7
NPM
NPM%
9.110.014.417.422.110.77.71.58.39.7
EPS
EPS₹
6.110.218.826.044.620.513.32.418.026.9
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
136206263300434424394383506650
Growth
Revenue Growth%
51.927.614.144.4-2.3-7.1-2.732.249.7
Expenses
ExpensesCr
113173208234325363325349413523
Operating Profit
Operating ProfitCr
2334556610861683493127
OPM
OPM%
16.916.420.922.125.014.317.38.918.419.5
Other Income
Other IncomeCr
1115928245
Interest Expense
Interest ExpenseCr
2444587137
Depreciation
DepreciationCr
345781026283740
PBT
PBTCr
19274861104454485784
Tax
TaxCr
771088-11321521
PAT
PATCr
1221385296453064263
Growth
PAT Growth%
67.284.038.383.5-52.6-33.3-81.2636.1254.7
NPM
NPM%
9.110.014.417.422.110.77.71.58.39.7
EPS
EPS₹
6.110.218.826.044.620.513.32.418.026.9
Sales CAGR
1 Year32%
3 Years6%
5 Years11%
TTM50%
EBITDA CAGR
1 Year172%
3 Years15%
5 Years7%
TTM128%
PAT CAGR
1 Year636%
3 Years-3%
5 Years-4%
TTM255%
Avg. ROCE
1 Year7%
3 Years5%
5 Years8%
TTM9%
CFO / EBITDA
1 Year34%
3 Years79%
5 Years56%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
88820222223232323
Reserves
ReservesCr
5172110146451493714715758791
Current Liabilities
Current LiabilitiesCr
6373881181712398096213296
Non Current Liabilities
Non Current LiabilitiesCr
223544311452199
Total Liabilities
Total LiabilitiesCr
1441882493156587598198361,0041,119
Current Assets
Current AssetsCr
77114133184436312298265350469
Non Current Assets
Non Current AssetsCr
6773116131222447521571654650
Total Assets
Total AssetsCr
1441882493156587598198361,0041,119
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
88820222223232323
Reserves
ReservesCr
5172110146451493714715758791
Current Liabilities
Current LiabilitiesCr
6373881181712398096213296
Non Current Liabilities
Non Current LiabilitiesCr
223544311452199
Total Liabilities
Total LiabilitiesCr
1441882493156587598198361,0041,119
Current Assets
Current AssetsCr
77114133184436312298265350469
Non Current Assets
Non Current AssetsCr
6773116131222447521571654650
Total Assets
Total AssetsCr
1441882493156587598198361,0041,119

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
13725202028982531
Investing Cash Flow
Investing Cash FlowCr
-30-17-40-21-197-101-121-65-116
Financing Cash Flow
Financing Cash FlowCr
71710-523538311779
Net Cash Flow
Net Cash FlowCr
-108-5-659-368-24-5
Free Cash Flow
Free Cash FlowCr
-18-2-23-1-69-175-30-51-82
CFO To PAT
CFO To PAT%
102.435.867.037.721.361.1323.0433.674.9
CFO To EBITDA
CFO To EBITDA%
54.921.846.129.618.845.9143.872.433.8
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
13725202028982531
Investing Cash Flow
Investing Cash FlowCr
-30-17-40-21-197-101-121-65-116
Financing Cash Flow
Financing Cash FlowCr
71710-523538311779
Net Cash Flow
Net Cash FlowCr
-108-5-659-368-24-5
Free Cash Flow
Free Cash FlowCr
-18-2-23-1-69-175-30-51-82
CFO To PAT
CFO To PAT%
102.435.867.037.721.361.1323.0433.674.9
CFO To EBITDA
CFO To EBITDA%
54.921.846.129.618.845.9143.872.433.8

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,1153,6952,5251,5882,4583,747
Price To Earnings
Price To Earnings
53.481.283.2278.358.559.5
Price To Sales
Price To Sales
11.88.76.44.24.95.8
Price To Book
Price To Book
10.87.23.42.13.14.6
EV To EBITDA
EV To EBITDA
46.763.136.747.127.630.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
38.737.740.340.644.436.841.934.441.841.8
OPM
OPM%
16.916.420.922.125.014.317.38.918.419.5
NPM
NPM%
9.110.014.417.422.110.77.71.58.39.7
ROCE
ROCE%
19.320.526.225.318.47.86.71.16.69.2
ROE
ROE%
20.825.832.131.520.38.84.10.85.47.7
ROA
ROA%
8.611.015.216.614.66.03.70.74.25.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,1153,6952,5251,5882,4583,747
Price To Earnings
Price To Earnings
53.481.283.2278.358.559.5
Price To Sales
Price To Sales
11.88.76.44.24.95.8
Price To Book
Price To Book
10.87.23.42.13.14.6
EV To EBITDA
EV To EBITDA
46.763.136.747.127.630.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
38.737.740.340.644.436.841.934.441.841.8
OPM
OPM%
16.916.420.922.125.014.317.38.918.419.5
NPM
NPM%
9.110.014.417.422.110.77.71.58.39.7
ROCE
ROCE%
19.320.526.225.318.47.86.71.16.69.2
ROE
ROE%
20.825.832.131.520.38.84.10.85.47.7
ROA
ROA%
8.611.015.216.614.66.03.70.74.25.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,6314,2244,0053,7473,4423,4272,716
Close PriceClose₹782.503,503.10928.301,601.80511.3575.581,792.70
IndustryIndustrySpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty Chemicals
Price To EarningsPE32.9248.8414.0659.5522.5522.1025.86
Price To SalesPS3.763.831.445.772.002.701.32
RevenueRevenueCr1,2331,1042,7856501,7251,2702,051
Revenue Growth TTMRev Gr TTM%54.1%12.9%49.7%14.1%9.5%17.2%
PAT Growth TTMPAT Gr TTM%580.5%-29.2%254.7%10.1%2.9%-15.1%
Market CapitalizationMkt CapCr4,6314,2244,0053,7473,4423,4272,716
Close PriceClose₹782.503,503.10928.301,601.80511.3575.581,792.70
IndustryIndustrySpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty ChemicalsSpecialty Chemicals
Price To EarningsPE32.9248.8414.0659.5522.5522.1025.86
Price To SalesPS3.763.831.445.772.002.701.32
RevenueRevenueCr1,2331,1042,7856501,7251,2702,051
Revenue Growth TTMRev Gr TTM%54.1%12.9%49.7%14.1%9.5%17.2%
PAT Growth TTMPAT Gr TTM%580.5%-29.2%254.7%10.1%2.9%-15.1%
Interviews